IBDEI03M ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4520,2)
 ;;=^31703
 ;;^UTILITY(U,$J,358.3,4521,0)
 ;;=780.4^^33^363^76
 ;;^UTILITY(U,$J,358.3,4521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4521,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,4521,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,4521,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,4522,0)
 ;;=345.90^^33^363^20
 ;;^UTILITY(U,$J,358.3,4522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4522,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,4522,1,5,0)
 ;;=5^Epilepsy
 ;;^UTILITY(U,$J,358.3,4522,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,4523,0)
 ;;=355.1^^33^363^38
 ;;^UTILITY(U,$J,358.3,4523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4523,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,4523,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,4523,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,4524,0)
 ;;=340.^^33^363^46
 ;;^UTILITY(U,$J,358.3,4524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4524,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,4524,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,4524,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,4525,0)
 ;;=729.2^^33^363^47
 ;;^UTILITY(U,$J,358.3,4525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4525,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,4525,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,4525,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,4526,0)
 ;;=053.19^^33^363^55
 ;;^UTILITY(U,$J,358.3,4526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4526,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,4526,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,4526,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,4527,0)
 ;;=310.9^^33^363^48
 ;;^UTILITY(U,$J,358.3,4527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4527,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,4527,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,4527,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,4528,0)
 ;;=332.0^^33^363^51
 ;;^UTILITY(U,$J,358.3,4528,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4528,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,4528,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,4528,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,4529,0)
 ;;=250.60^^33^363^52
 ;;^UTILITY(U,$J,358.3,4529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4529,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,4529,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,4529,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,4530,0)
 ;;=356.9^^33^363^54
 ;;^UTILITY(U,$J,358.3,4530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4530,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,4530,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,4530,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,4531,0)
 ;;=780.2^^33^363^68
 ;;^UTILITY(U,$J,358.3,4531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4531,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,4531,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,4531,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,4532,0)
 ;;=724.3^^33^363^64
 ;;^UTILITY(U,$J,358.3,4532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4532,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,4532,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,4532,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,4533,0)
 ;;=780.39^^33^363^66
 ;;^UTILITY(U,$J,358.3,4533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4533,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,4533,1,5,0)
 ;;=5^Seizure NOS
 ;;^UTILITY(U,$J,358.3,4533,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,4534,0)
 ;;=782.0^^33^363^50
 ;;^UTILITY(U,$J,358.3,4534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4534,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,4534,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,4534,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,4535,0)
 ;;=435.9^^33^363^73
 ;;^UTILITY(U,$J,358.3,4535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4535,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,4535,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,4535,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,4536,0)
 ;;=354.2^^33^363^75
 ;;^UTILITY(U,$J,358.3,4536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4536,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,4536,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,4536,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,4537,0)
 ;;=729.1^^33^363^21
 ;;^UTILITY(U,$J,358.3,4537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4537,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,4537,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,4537,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,4538,0)
 ;;=438.20^^33^363^6
 ;;^UTILITY(U,$J,358.3,4538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4538,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,4538,1,5,0)
 ;;=5^CVA w/ Hemiplegia (Late Effect)
 ;;^UTILITY(U,$J,358.3,4538,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,4539,0)
 ;;=438.12^^33^363^5
 ;;^UTILITY(U,$J,358.3,4539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4539,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,4539,1,5,0)
 ;;=5^CVA w/ Dysphasia (Late Effect)
 ;;^UTILITY(U,$J,358.3,4539,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,4540,0)
 ;;=356.8^^33^363^53
 ;;^UTILITY(U,$J,358.3,4540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4540,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,4540,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,4540,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,4541,0)
 ;;=337.20^^33^363^61
 ;;^UTILITY(U,$J,358.3,4541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4541,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,4541,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,4541,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,4542,0)
 ;;=294.8^^33^363^18
 ;;^UTILITY(U,$J,358.3,4542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4542,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,4542,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,4542,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,4543,0)
 ;;=438.6^^33^363^4
 ;;^UTILITY(U,$J,358.3,4543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4543,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,4543,1,5,0)
 ;;=5^CVA w/ Dysesthesia (Late Effect)
 ;;^UTILITY(U,$J,358.3,4543,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,4544,0)
 ;;=438.7^^33^363^7
 ;;^UTILITY(U,$J,358.3,4544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4544,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,4544,1,5,0)
 ;;=5^CVA w/ Vision Changes (Late Effect)
 ;;^UTILITY(U,$J,358.3,4544,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,4545,0)
 ;;=438.84^^33^363^3
 ;;^UTILITY(U,$J,358.3,4545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4545,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,4545,1,5,0)
 ;;=5^CVA w/ Ataxia (Late Effect)
 ;;^UTILITY(U,$J,358.3,4545,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,4546,0)
 ;;=434.91^^33^363^8
 ;;^UTILITY(U,$J,358.3,4546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4546,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,4546,1,5,0)
 ;;=5^CVA,Acute Onset
 ;;^UTILITY(U,$J,358.3,4546,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,4547,0)
 ;;=V12.54^^33^363^22
 ;;^UTILITY(U,$J,358.3,4547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4547,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,4547,1,5,0)
 ;;=5^HX Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,4547,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,4548,0)
 ;;=333.94^^33^363^62
 ;;^UTILITY(U,$J,358.3,4548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4548,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,4548,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,4548,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,4549,0)
 ;;=345.90^^33^363^65
 ;;^UTILITY(U,$J,358.3,4549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4549,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,4549,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,4549,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,4550,0)
 ;;=339.00^^33^363^10
 ;;^UTILITY(U,$J,358.3,4550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4550,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,4550,1,5,0)
 ;;=5^Cluster Headache, Unsp
 ;;^UTILITY(U,$J,358.3,4550,2)
 ;;=^336741
 ;;^UTILITY(U,$J,358.3,4551,0)
 ;;=339.01^^33^363^12
 ;;^UTILITY(U,$J,358.3,4551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4551,1,4,0)
 ;;=4^339.01
 ;;^UTILITY(U,$J,358.3,4551,1,5,0)
 ;;=5^Cluster Headache,Episodic
 ;;^UTILITY(U,$J,358.3,4551,2)
 ;;=^336545
 ;;^UTILITY(U,$J,358.3,4552,0)
 ;;=339.02^^33^363^11
 ;;^UTILITY(U,$J,358.3,4552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4552,1,4,0)
 ;;=4^339.02
 ;;^UTILITY(U,$J,358.3,4552,1,5,0)
 ;;=5^Cluster Headache,Chronic
 ;;^UTILITY(U,$J,358.3,4552,2)
 ;;=^336546
 ;;^UTILITY(U,$J,358.3,4553,0)
 ;;=339.81^^33^363^25
 ;;^UTILITY(U,$J,358.3,4553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4553,1,4,0)
 ;;=4^339.81
 ;;^UTILITY(U,$J,358.3,4553,1,5,0)
 ;;=5^Headache, Hypnic
 ;;^UTILITY(U,$J,358.3,4553,2)
 ;;=^336560
 ;;^UTILITY(U,$J,358.3,4554,0)
 ;;=339.3^^33^363^26
 ;;^UTILITY(U,$J,358.3,4554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4554,1,4,0)
 ;;=4^339.3
 ;;^UTILITY(U,$J,358.3,4554,1,5,0)
 ;;=5^Headache, Med Induced
 ;;^UTILITY(U,$J,358.3,4554,2)
 ;;=^336555
 ;;^UTILITY(U,$J,358.3,4555,0)
 ;;=339.82^^33^363^24
 ;;^UTILITY(U,$J,358.3,4555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4555,1,4,0)
 ;;=4^339.82
 ;;^UTILITY(U,$J,358.3,4555,1,5,0)
 ;;=5^Headache w/ Sexual Activity
 ;;^UTILITY(U,$J,358.3,4555,2)
 ;;=^336561
 ;;^UTILITY(U,$J,358.3,4556,0)
 ;;=339.42^^33^363^27
 ;;^UTILITY(U,$J,358.3,4556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4556,1,4,0)
 ;;=4^339.42
 ;;^UTILITY(U,$J,358.3,4556,1,5,0)
 ;;=5^Headache, NDPH
 ;;^UTILITY(U,$J,358.3,4556,2)
 ;;=^336557
 ;;^UTILITY(U,$J,358.3,4557,0)
 ;;=339.83^^33^363^30
 ;;^UTILITY(U,$J,358.3,4557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4557,1,4,0)
 ;;=4^339.83
 ;;^UTILITY(U,$J,358.3,4557,1,5,0)
 ;;=5^Headache, Primary Cough
 ;;^UTILITY(U,$J,358.3,4557,2)
 ;;=^336562
 ;;^UTILITY(U,$J,358.3,4558,0)
 ;;=339.84^^33^363^31
